Local control of the immune response in the liver

Immunological Reviews

Volumn 174, Issue , 2000, Pages 21-34

  Knolle, Percy A ^a   Gerken, Guido ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; CD86 ANTIGEN; CYTOKINE; ENDOTOXIN; GASTROINTESTINAL HORMONE; IMMUNOSUPPRESSIVE AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA;

ANTIBACTERIAL ACTIVITY; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; APOPTOSIS; CELL INTERACTION; CELL POPULATION; ENDOCYTOSIS; ENDOTHELIUM CELL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; KUPFFER CELL; LEUKOCYTE; LIVER; LIVER CELL; LIVER CLEARANCE; LIVER FUNCTION; LIVER METABOLISM; LIVER SINUSOID; MACROPHAGE; NONHUMAN; PATHOGENICITY; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SUPPRESSOR CELL; SYSTEMIC CIRCULATION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, BACTERIAL; APOPTOSIS; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC SURVEILLANCE; INTESTINAL ABSORPTION; KUPFFER CELLS; LEUKOCYTES; LIPOPOLYSACCHARIDES; LIVER; LIVER CIRCULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MACROPHAGE ACTIVATION; MICE; MICE, TRANSGENIC;

EID: 0034031683     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0528.2002.017408.x     Document Type: Review

References (96)

1. 1. Cantor H, Dumont A. Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 1967;215:744.
2. 2. May AG, Bauer S, Leddy JP, Panner B, Vaughan J, Russell PS. Survival of allografts after hepatic portal venous administration of specific transplantation antigen. Ann Surg 1969;170:824-832.
3. 3. Gorczynski RM. Immunosuppression induced by hepatic portal venous immunization spares reactivity in IL-4 producing T lymphocytes. Immunol Lett 1992;33:67-77.
4. 4. Barker CF, Corriere JN Jr. Canine renal homotransplantation with venous drainage via the portal vein. Ann Surg 1967;165:279-282.
5. 5. Boeckx W, Sobis H, Lacquet A, Gruwez J, Vandeputte M. Prolongation of allogeneic heart graft survival in the rat after implantation on portal vein. Transplantation 1975;19:145-149.
6. 6. Gorczynski RM, et al. Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage. Transplantation 1994;58:816-820.
7. 7. Calne RY. Induction of immunological tolerance by porcine liver allografts. Nature 1969;223:472-476.
8. 8. Wisse E, De Zanger RB, Charels K, Van Der Smissen P, McCuskey RS. The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Dissé. Hepatology 1985;5:683-692.
9. 9. Wisse E. An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids. J Ultrastruct Res 1970;31:125-150.
10. 10. Kolb-Bachofen V, Schlepper-Schafer J, Roos P, Hulsmann D, Kolb H. GalNAc/Gal-specific rat liver lectins: their role in cellular recognition. Biol Cell 1984;51:219-226.
11. 11. Schlepper-Schafer J, et al. Endocytosis via galactose receptors in vivo. Ligand size directs uptake by hepatocytes and/or liver macrophages. Exp Cell Res 1986;165:494-506.
12. 12. Kempka G, Kolb-Bachofen V. Binding, uptake, and transcytosis of ligands for mannose-specific receptors in rat liver: an electron microscopic study. Exp Cell Res 1988;176.38-48.
13. 13. Fraser R, Dobbs BR, Rogers GW. Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 1995;21:863-374.
14. 14. Blomhoff R, Eskild W, Berg T. Endocytosis of formaldehyde-treated serum albumin via scavenger pathway in liver endothelial cells. Biochem J 1984;218:81-86.
15. 15. Smedsrod B, Pertoft H, Gustafson S, Laurent TC. Scavenger functions of the liver endothelial cell. Biochem J 1990;266:313-327.
16. 16. Magnusson S, Berg T. Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial rat liver cells. Biochem J 1989;257:651-656.
17. 17. Melkko J, Hellevik T, Risteli L, Risteli J, Smedsrod B. Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med 1994;179:405-412.
18. 18. Smedsrod B, Melkko J, Araki N, Sano H, Horiuchi S. Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells. Biochem J 1997;322:567-573.
19. 19. Tavassoli M, Kishimoto T, Soda R, Kataoka M, Harjes K. Liver endothelíum mediates the uptake of iron-transferrin complex by hepatocytes. Exp Cell Res 1986;165:369-379.
20. 20. Tavassoli M, Kishimoto T, Kataoka M. Liver endothelium mediates the hepatocyte's uptake of ceruloplasmin. J Cell Biol 1986;102:1298-1303.
21. 21. Irie S, Kishimoto T, Tavassoli M. Desialation of transferrin by rat liver endothelium. J Clin Invest 1988;82:508-513.
22. 22. MacPhee PJ, Schmidt EE, Groom AC. Intermittence of blood flow in liver sinusoids, studied by high-resolution in vivo microscopy. Am J Physiol 1995;269:G692-G698.
23. 23. MacPhee PJ, Schmidt EE, Groom AC. Evidence for Kupffer cell migration along liver sinusoids, from high-resolution in vivo microscopy. Am J Physiol 1992;263:G17-G23.
24. 24. McNab G, Reeves JL, Salmi M, Hubscher S, Jalkanen S, Adams DH. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology 1996;110:522-528.
25. 25. Wong J, et al. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest 1997;99:2782-2790.
26. 26. Jaeschke H, Farhood A, Smith CW. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol 1991;261:G1051-G1056.
27. 27. Shnyra A, Lindberg AA. Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro. Infect Immun 1995;63:865-873.
28. 28. Steffan AM, Gendrault JL, McCuskey RS, McCuskey PA, Kirn A. Phagocytosis, an unrecognized property of murine endothelial liver cells. Hepatology 1986;6:830-836.
29. 29. Winwood PJ, Arthur MJ. Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin Liver Dis 1993;13:50-59.
30. 30. Kosugi I, Muro H, Shirasawa H, Ito I. Endocytosis of soluble IgG immune complex and its transport to lysosomes in hepatic sinusoidal endothelial cells. J Hepatol 1992;16:106-114.
31. 31. Rubinstein D, Roska AK, Lipsky PE. Liver sinusoidal lining cells express class II major histocompatibility antigens but are poor stimulators of fresh allogeneic T lymphocytes. J Immunol 1986;137:1803-1810.
32. 32. Rubinstein D, Roska AK, Lipsky PE. Antigen presentation by liver sinusoidal lining cells after antigen exposure in vivo. J Immunol 1987;138:1377-1382.
33. 33. Lohse AW, et al. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 1996;110:1175-1181.
34. 34. Knolle PA, et al. IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules. Clin Exp Immunol 1998;114:427-433.
35. 35. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995;182:389-400.
36. 36. Briscoe DM, Henault LE, Geehan C, Alexander SI, Lichtman AH. Human endothelial cell costimulation of T cell IFN-γ production. J Immunol 1997;159:3247-3256.
37. 37. Johnson DR, Hauser IA, Voll RE, Emmrich F. Arterial and venular endothelial cell costimulation of cytokine secretion by human T cell clones. J Leukoc Biol 1998;63:612-619.
38. + T cells. J Immunol 1998;161:2158-2167.
39. 39. Perez VL, Henault L, Lichtman AH. Endothelial antigen presentation: stimulation of previously activated but not naive TCR-transgenic mouse T cells. Cell Immunol 1998;189:31-40.
40. 40. Autschbach F, et al. Hepatocellular expression of lymphocyte function-associated antigen 3 in chronic hepatitis. Hepatology 1991;14:223-230.
41. 41. Meuer SC, et al. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell 1984;36:897-906.
42. 42. Scoazec JY, Feldmann G. Both macrophages and endothelial cells of the human hepatic sinusoid express the CD4 molecule, a receptor for the human immunodeficiency virus. Hepatology 1990;12:505-510.
43. + T cells: implications for tolerance induction in the liver. Gastroenterology 1999;116:1428-1440.
44. 44. Jacob AI, Goldberg PK, Bloom N, Degenshein GA, Kozinn PJ. Endotoxin and bacteria in portal blood. Gastroenterology 1977;72:1268-1270.
45. 45. Lumsden AB, Henderson JM, Kutner MH. Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis. Hepatology 1988;8:232-236.
46. 46. Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde KH, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol 1995;22:226-229.
47. 47. Knolle PA, et al. Interleukin-10 expression is autoregulated at the transcriptional level in human and murine Kupffer cells. Hepatology 1998;27:93-99.
48. 48. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
49. 49. Barsig J, Kusters S, Vogt K, Volk HD, Tiegs G, Wendel A. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-α. Eur J Immunol 1995;25:2888-2893.
50. + exchange. Eur J Biochem 1987;170:201-206.
51. 51. Grewe M, Duyster J, Dieter P, Henninger H, Schulze-Specking A, Decker K. Prostaglandin D2 and E2 syntheses in rat Kupffer cells are antagonistically regulated by lipopolysaccharide and phorbol ester. Biol Chem Hoppe Seyler 1992;373:655-664.
52. 52. Rieder H, Ramadori G, Allmann KH, Meyer zum Buschenfelde KH. Prostanoid release of cultured liver sinusoidal endothelial cells in response to endotoxin and tumor necrosis factor. Comparison with umbilical vein endothelial cells. J Hepatol 1990;11:359-366.
53. 53. Freudenberg MA, Freudenberg N, Galanos C. Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats. Br J Exp Pathol 1982;63:56-65.
54. 54. Knolle PA, et al. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells. J Immunol 1999;162:1401-1407.
55. 55. Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-β in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995;96:447-455.
56. 56. Knolle P, et al. Parenchymal and nonparenchymal liver cells and their interaction in the local immune response. Z Gastroenterol 1995;33:613-620.
57. 57. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992;90:196-203.
58. 58. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995;21:190-198.
59. 59. Knolle PA, et al. Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice. Hepatology 1996;24:824-829.
60. + T cells. Immunology 1994;81:27-35.
61. 61. Dini L, Carla EC. Hepatic sinusoidal endothelium heterogeneity with respect to the recognition of apoptotic cells. Exp Cell Res 1998;240:388-393.
62. 62. Müschen M, Warskulat U, Douillard P, Gilbert E, Häussinger D. Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells. Hepatology 1998;27:200-208.
63. 63. Müschen M, Warskulat U, Peters-Regehr T, Bode JG, Kubitz R, Häussinger D. Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation. Gastroenterology 1999;116:666-677.
64. + T lymphocytes but fail to promote survival. Eur J Immunol 1998;28:221-236.
65. 65. Galle PR, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230.
66. 66. Huang L, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994;1:741-749.
67. 67. Cooper S, et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999;10:439-449.
68. 68. Crispe IN, Mehal WZ. Strange brew: T cells in the liver. Immunol Today 1996;17:522-525.
69. 69. Kamada N, Wight DG. Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation 1984;38:217-221.
70. 70. Gorczynski RM, Chen Z, Hoang Y, Rossi-Bergman B. A subset of γδ T-cell receptor-positive cells produce T helper type-2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization. Immunology 1996;87:381-389.
71. 71. Gorczynski RM, Hozumi N, Wolf S, Chen Z. Interleukin 12 in combination with anti-interleukin 10 reverses graft prolongation after portal venous immunization. Transplantation 1995;60:1337-1341.
72. 72. Gorczynski RM. Regulation of IFN-γ and IL-10 synthesis in vivo, as well as continuous antigen exposure, is associated with tolerance to murine skin allografts. Cell Immunol 1995;160:224-231.
73. 73. Gorczynski L, et al. Evidence that an OX-2-positive cell can inhibit the stimulation of type 1 cytokine production by bone marrow-derived B7-1 (and B7-2)-positive dendritic cells. J Immunol 1999;162:774-781.
74. 74. Cossel L. Electron microscopy of Kupffer cells in the orthotopic porcine liver homograft during the late stage after transplantation (phagocytosis of host cells by Kupffer cells). Exp Pathol (Jena) 1975;11:168-181.
75. 75. Falasca L, Bergamini A, Serafino A, Balabaud C, Dini L. Human Kupffer cell recognition and phagocytosis of apoptotic peripheral blood lymphocytes. Exp Cell Res 1996;224:152-162.
76. 76. Gallery MP, Kamei T, Flye MW. Kupffer cell blockade inhibits induction of tolerance by the portal venous route. Transplantation 1989;47:1092-1094.
77. 77. Kamei T, Callery MP, Flye MW. Kupffer cell blockade prevents induction of portal venous tolerance in rat cardiac allograft transplantation. J Surg Res 1990;48:393-396.
78. 78. Roland CR, Mangino MJ, Duffy BF, Flye MW. Lymphocyte suppression by Kupffer cells prevents portal venous tolerance induction: a study of macrophage function after intravenous gadolinium. Transplantation 1993;55:1151-1158.
79. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
80. 80. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 1997;159:4772-4780.
81. 81. Gregory SH, Sagnimeni AJ, Wing EJ. Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J Immunol 1996;157:2514-2520.
82. 82. Limmer A, et al. Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment. Eur J Immunol 1998;28:2395-2406.
83. 83. Limmer A, Sacher T, Alferink J, Nichterlein T, Arnold B, Hämmerling GJ. A two-step model for the induction of organ-specific autoimmunity. Novartis Found Symp 1998;215:159-167.
84. + T cells and antibodies required for immunity to malaria sporozoites. Nature 1987;330:664-666.
85. 85. Ferreira A, et al. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science 1986;232:881-884.
86. 86. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996;4:25-36.
87. 87. Weiner H, et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994;12:809-838.
88. 88. Yang R, Q Liu, JL Grosfeld, MD Pescovitz. Intestinal venous drainage through the liver is a prerequisite for oral tolerance induction. J Pediatr Surg 1994;29:1145-1148.
89. 89. Callery MP, Kamei T, Flye MW. The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J Surg Res 1989;46:391-394.
90. 90. Gutgemann I, Fahrer AM, Altman JD, Davis MM, Chien YH. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 1998;8:667-673.
91. 91. Kiyono H, McGhee JR, Wannemuehler MJ, Michalek SM. Lack of oral tolerance in C3H/HeJ mice. J Exp Med 1982;155:605-610.
92. + T cells in the liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci USA 1998;95:13812-13817.
93. 93. Breiner KM, Urban S, Schaller H. Carboxypeptidase D (gp180), a Golgi-resident protein, functions in the attachment and entry of avian hepatitis B viruses. J Virol 1998;72:8098-8104.
94. 94. Ando K, Guidotti LG, Cerny A, Ishikawa T, Chisari FV. CTL access to tissue antigen is restricted in vivo. J Immunol 1994;153:482-488.
95. 95. Matsuno K, Ezaki T, Kudo S, Uehara Y. A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph. J Exp Med 1996;183:1865-1878.
96. 96. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997;99:1472-1477.